4D Molecular Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
4D Molecular Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • 4D Molecular Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $6.49M, a 42.3% increase year-over-year.
  • 4D Molecular Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $24.5M, a 35.1% increase year-over-year.
  • 4D Molecular Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $19.7M, a 14.9% increase from 2022.
  • 4D Molecular Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $17.1M, a 24.1% increase from 2021.
  • 4D Molecular Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $13.8M, a 177% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $19.7M +$2.54M +14.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $17.1M +$3.32M +24.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $13.8M +$8.82M +177% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 $4.98M +$1.44M +40.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $3.54M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.